Escolar Documentos
Profissional Documentos
Cultura Documentos
McGraw-Hill/Irwin Copyright © 2010 by The McGraw-Hill Companies, Inc. All rights reserved.
The Analysis of the
Balance Sheet and
Income Statement
What you will learn from this chapter
• How operating and financing components of the two statements are identified
• Which assets and liabilities typically fall into operating and financing
categories
• Why income taxes are allocated to different parts of the income statement
• How one learns about the firm’s strategy through the financial statements
9-3
Analysis of Balance Sheet and Income
Statement: the Steps
9-4
The Standard Balance Sheet
Assets Liabilities and Stockholders’ Equity
Intangible assets
Patents Minority interest
Copyrights
Goodwill
Shareholders’ equity
Deferred taxes (non-current) Preferred equity
Deferred charges Common equity
9-5
Reformulating the Balance Sheet:
The Governing Accounting Relations
Net Operating Assets (NOA) = Operating Assets (OA) – Operating Liabilities (OL)
Net Financial Obligations (NFO) = Financial Obligations (FO) – Financial Assets (FA)
9-6
The Typical Reformulated Balance Sheet
Minority interest
Common equity
9-7
Issues in Reformulating Balance Sheets
9-8
GAAP Balance Sheet: Nike Inc.
9-9
Reformulated Balance Sheet: Nike Inc.
9-10
Nike Inc.: Notes on the Reformulation
9-11
Strategic Balance Sheets
9-12
Strategic Balance Sheet: Microsoft Corporation
Year ending June 30 2002 2001
Operating assets:
Working cash1 $ 50 $ 50
Account receivable, net 5,129 3,671
Inventories 673 83
Deferred income taxes 2,112 1,522
Property and equipment, net 2,268 2,309
Equity investments 9,151 8,780
Convertible preferred debt2 3,036 3,925
Goodwill 1,426 1,511
Intangible assets, net 243 401
Other assets 2,952 3,372
27,040 25,624
Operating liabilities
Accounts payable 1,208 $ 1,188
Accrued compensation 1,145 742
Income taxes payable 2,022 1,468
Unearned revenue 7,743 5,614
Preferred income taxes 398 409
Other liabilities 2,950 15,466 2,120 11,541
11,574 14,083
Net financial assets
Cash equivalents 2,966 3,872
Short-term investments 35,636 27,678
Long-term debt investments 2,004 40,606 1,656 33,206
1
Cash and cash equivalents split between working cash and financial assets.
2
Convertible debt of AT&T Corp. in connection with investment in broadband.
9-13
Strategic Balance Sheet: Dell Inc.
9-14
Strategic Balance Sheet: General Mills Inc.
9-15
The Standard Income Statement
Net sales (sales minus sales allowances)
+ Other revenue (royalties, rentals, license fees)
- Cost of sales
= Gross margin
- Marketing and advertising expenses
- General expenses
- Administrative expenses
- ± Special items and nonrecurring items
Restructuring charges
Merger expenses
Gains and losses on asset sales
Asset impairments
Litigation settlements
Environmental remediation
- Research and development expense
+ Interest revenue
- Interest (expense)
Realized gains and losses on financial assets
± Unrealized gains and losses on trading securities
+ Share of income of subsidiary
- Income taxes
= Income before extraordinary items and discontinued operations
Discontinued operations
Extraordinary items
Gains and losses on debt retirement
Abnormal gains and losses
- Minority interest
Net sales
– Expenses to generate sales
Operating income from sales (before tax)
– Tax on operating income from sales
+ Tax as reported
+ Tax benefit from net financial expenses
– Tax allocated to other operating income
Operating income from sales (after tax)
±Other operating income (expense) requiring tax allocation
Restructuring charges and asset impairments
Merger expenses
Gains and losses on asset sales
Gains and losses on security transactions
− Tax on other operating income
± After-tax operating items
Equity share in subsidiary income
Operating items in extraordinary income
Dirty-surplus operating items in Table 8.1
Hidden-dirty surplus operating items
Operating income (after tax)
9-17
The Reformulated Income Statement (cont.)
9-18
The Allocation of Taxes
• In the income statement only one tax number is reported: It must be allocated to
the operating and financial components to put both on an after-tax basis
• First, calculate the tax benefit (tax shield) provided by deducting interest expense
Tax Benefit Net Interest Expense t
where t is the marginal (not effective) tax rate. The statutory rate is usually the
marginal rate.
• From the operating income deduct both the total tax and the tax benefit, to capture
what the operating income would have been, after tax, had there been no financing
activities
• To the net financial expense add the tax benefit, because its net effect is
attributable to the financing activities
9-19
Top-down and Bottom-up Methods for Tax Allocation:
Tax Rate = 35%
GAAP Top-down Bottom-up
Income Statement Tax Allocation Tax Allocation
Revenue $4,000
Operating expenses (3,400)
Interest expense (100)
Income before tax 500
Income tax expense (150)
Net income $ 350
Revenue $4000
Operating expenses (3,400)
Operating income before tax 600
Tax expense:
Tax reported $150
Tax benefit for interest 35 (185)
($100 x 0.35)
Operating income after tax $ 415
9-20
Additional Tax Allocation within Operations
• Remember: some other operating income items are after tax (if
they appear below the tax line on the GAAP statement)
9-21
GAAP Income Statement: Nike Inc.
9-22
Starting Point for Income Statement Reformulation:
Identify Comprehensive Income from Equity Statement
9-23
Reformulated Income Statement: Nike Inc.
9-24
Nike Inc.: Notes on Reformulated Income Statement
9-25
Strategic Income Statements
Value added in operations: How are operations adding value to the book
value of operations?
9-26
GAAP Income Statement: Microsoft Corporation
Year Ended June 30 2002 2001
__________________________________________________________________________________
Revenue $ 28,365 $ 25,296
Operating expenses:
Cost of revenue 5,191 3,455
Research and development 4,307 4,379
Sales and marketing 5,407 4,885
General and administrative 1,550 857
----------------------------------------------------------------------------------
Total operating expenses 16,455 13,576
----------------------------------------------------------------------------------
----------------------------------------------------------------------------------
----------------------------------------------------------------------------------
9-27
Strategic Income Statement: Microsoft Corporation
Year ended June 2002 2001
Operating expenses:
Cost of revenue 5,191 3,455
Research and development 4,307 4,379
Sales and marketing 5,407 4,885
General and administrative 1,550 857
16,455 13,576
9-28
Strategic Income Statement: Dell Inc.
9-29
Value Added to Strategic Balance Sheets: Dell Inc.
For Dell,
9-30
Strategic Income Statement: General Mills Inc.
9-31
Comparative Analysis
9-32
Common Size Analysis:
Nike and General Mills Income Statements
Nike General Mills
$ % $ %
Operating expenses
Administrative 3,645 19.6 1,792 13.1
Advertising 2,308 12.4 628 4.6
Amortization and other 69 0.4 205 1.5
Operating income from sales 2,365 12.7 2,249 16.5
(before tax)
9-33
Common Size Analysis:
Nike and General Mills Balance Sheets (Operating
Section)
Nike General Mills
$ % $ %
Operating assets
Cash 93 0.9 50 0.3
Accounts renewable 2,795 28.6 1,082 5.9
Inventories 2,438 25.0 1,367 7.4
Prepaid expenses 602 6.2 511 2.8
Property, plant and equipment 1,891 19.4 3,108 16.9
Goodwill 449 4.6 6,786 36.8
Identifiable intangibles 743 7.6 3,777 20.5
Deferred taxes and other assets 748 7.7 1,750 9.5
9,760 100.0 18,431 100.0
Operating liabilities
Accounts payable 1,222 30.9 937 16.8
Accrued liabilities 1,790 45.3 3,164 56.7
Income taxes payable 88 2.2 - -
Deferred taxes and other 854 21.6 1,483 26.6
3,954 100.0 5,584 100.0
9-34
Trend Analysis: Nike Inc.
9-35
Income Statement Ratios
Profit margin ratios
Operating Profit Margin:
OI (after tax)
Sales
9-36
Income Statement Ratios (cont.)
• Expense Ratios
Expense Ratio
9-37
Balance Sheet Leverage Ratios
Capitalization Ratio:
NOA
CSE
Operating Liabilities
Net Operating Assets
9-38
Growth Ratios
Change in Sales
Growth Rate in Sales =
Prior Period' s Sales
Change in CSE
Growth in CSE =
Beginning CSE
9-39
Summary Profitability Measures
Operating Profitability:
OI t
RNOA t =
1
NOA t +NOA t-1
2
Financing Profitability:
NFE t
NBC t =
1
NFO t +NFO t-1
2
or
NFI t
RNFA t =
1
NFA t +NFA t-1
2
9-40
Financial Statement Analysis Procedures
1. Reformulate the statement of stockholders’ equity on clean surplus
basis (Chapter 8)
2. Calculate comprehensive rate of return on common equity, ROCE,
from reformulated statement of common stockholders’ equity
(Chapter 8)
3. Reformulate the balance sheet to distinguish operating and financial
assets and obligations
4. Reformulate the income statement on clean surplus basis and
distinguish operating and financing income
5. Compare reformulated balance sheets and income statements with
reformulated statements of comparison firms, and over time, with a
common size analysis and a trend analysis
6. Calculate balance sheet and income statement ratios
7. Carry out the analysis of ROCE: Chapter 11
8. Carry out the analysis of growth: Chapter 12
9-41
Additional Examples of
Reformulated Statements
Follow
9-42
January 2 January 2
VF Corporation 1999 1998
1998 Reported ASSETS
Current Assets
Balance Sheet Cash and equivalents S $ 63,208 $ 124,094
Accounts receivable, less allowances O 705,734 587,934
Inventories O 954,007 774,755
Deferred income taxes O 99,608 94,750
Other current assets O 25,595 19,933
Total current assets 1,848,152 1,601,466
Property, plant and equipment O 776,091 705,990
Intangible assets O 951,562 814,332
Other assets O 260,861 200,994
$3,836,666 $3,322,782
========== ==========
OPERATING LIABILITIES
Accounts payable 341,126 301,103
Accrued liabilities 446,001 440,164
Other liabilities 181,750 143,813
Operating liabilities 968,877 885,080
9-44
VF Corporation 1998
Reported Income
Statement
FISCAL YEAR ENDED JANUARY 2 JANUARY3
1999 1998
O NET SALES $5,478,807 $5,222,246
COSTS AND OPERATING EXPENSES
O Cost of products sold 3,586,686 3,440,611
O Marketing, administrative & general expenses 1,198,854 1,175,598
O Other operating expense 9,098 964
4,794,638 4,617,173
OPERATING INCOME 684,169 605,073
OTHER INCOME (EXPENSE)
F Interest income 6,411 23,818
F Interest expense (62,282) (49,695)
O Miscellaneous, net 3,300 6,684
(52,571) (19,193)
INCOME BEFORE INCOME TAXES 631,598 585,880
S INCOME TAXES 243,292 234,938
NET INCOME 388,306 350,942
9-45
VF Corporation 1998
Reformulated Income Statement
FISCAL YEAR ENDED JANUARY 2 JANUARY3
1999 1998
Net sales $5,478,807 $5,222,246
Cost of products sold (3,586,686) (3,440,611)
Gross margin 1,892,121 1,781,635
Miscellaneous income 3,300 6,684
1,895,421 1,788,319
Advertising expense 287,500 309,300
Administrative and general expense 911,354 866,298
Other expense 9,098 (1,207,952) 964 (1,176,562)
687,469 611,757
Tax benefit on preferred dividends to ESOP 568 700
Foreign currency translation adjustment 10,471 (42,538)
Operating income before tax 698,508 569,919
Tax reported 243,292 234,938
Tax benefit of debt 21,231 264,523 9,833 244,771
Operating income after tax 433,985 325,148
Net financial expense
Interest expense 62,282 49,695
Interest income (6,411) (23,818)
Net interest before tax 55,871 25,877
Tax benefit of debt (38%) (21,231) (9,833)
Net interest after tax 34,640 16,044
Preferred dividends 3,717 3,804
Preferred stock redemption loss 2,763 41,120 1,855 21,703
Comprehensive income (available to common) $ 392,862 $ 303,445
========== ==========
9-46
Genentech, Inc. 1995
Reported Balance Sheet
1995 1994
ASSETS:
Current assets
Cash and cash equivalents $ 137,043 S $ 66,713
Short-term investments 603,296 F 652,461
Accounts receivable (less allowances) 172,160 O 146,267
Logo used with permission of Genetech, Inc.
9-47
Genentech, Inc. 1995
Reported Balance Sheet
1995 1994
LIABILITIES AND SHAREHOLDERS’ EQUITY:
Current liabilities:
Accounts payable $ 37,101 O $ 30,963
Accrued compensation 36,945 O 36,939
Accrued royalties 23,159 O 25,864
Accrued marketing and promotion costs 18,863 O 27,463
Accrued clinical and other studies 33,621 36,277
Logo used with permission of Genetech, Inc.
O
Income taxes payable 14,329 O 17,839
Other accrued liabilities 69,068 O 44,283
Current portion of long-term debt 358 F 871
Total current liabilities 233,444 220,499
Long-term debt 150,000 F 150,358
Other long-term liabilities 25,504 O 25,483
Total liabilities 408,948 396,340
Stockholders' equity:
Preferred stock - F -
Special common stock 853 -
Redeemable common stock - 1,002
Common stock 1,532 1,343
Additional paid-in capital 1,281,640 1,207,720
Retained earnings 263,749 129,127
Net unrealized gain on securities
available for sale 54,273 9,592
Total stockholders' equity 1,602,047 1,348,784
Total liabilities and stockholders' equity $2,010,995 $1,745,124
========== ==========
9-48
1995 1994
OPERATING ASSETS
Cash $ 10,000 $ 10,000
Accounts receivable, less allowances 172,160 146,267
Genentech, Inventories 93,648 103,200
Prepaid expenses and other current assets 39,267 28,475
Inc. 1995 Property, plant and equipment 503,654 485,293
Other assets 105,452 60,989
Reformulate Operating assets 924,181 834,224
d Balance
OPERATING LIABILITIES
Sheet Accounts payable 37,101 30,963
Accrued compensation 36,945 36,939
Accrued royalties 23,159 25,864
Logo used with permission of Genetech, Inc.
9-49
Genentech, Inc. 1995
Reported Income Statement
YEAR ENDED DECEMBER 31 1995 1994
Revenues
O Product sales $635,263 $601,064
O Royalties 190,811 126,022
O Contract and other 31,209 25,556
F Interest 60,562 42,748
Logo used with permission of Genetech, Inc.
9-50
Genentech, Inc. 1995 Reformulated
Income Statement
Operating income:
Operating revenues $857,283
Operating expenses 712,632
Special merger charge 25,000 737,632
Operating income before tax 119,651
Logo used with permission of Genetech, Inc.
Financial income:
Interest revenue 60,562
Interest expense 7,940
Net interest income before tax 52,622
Tax on net interest income (.39) 20,523
Net interest income after tax 32,099
Unrealized gain on securities 44,681
Net financial income 76,780
9-51
Common Size Income Statement for Genentech, Amgen & Chiron
Genentech Amgen Chiron
$ % $ % $ %
Operating revenues before other items:
Product sales (unrelated parties) 635.3 74.1 1,818.6 93.7 922.9 90.5
Royalties 190.8 22.3 36.1 1.9 39.3 3.9
Re venues partners and agreements 31.2 3.6 85.2 4.4 58.1 5.7
Operating revenue 857.3 100.0 1,939.9 100.0 1,020.3 100.0
Operating expenses before other items:
Cost of sales 97.9 11.4 272.9 14.1 415.8 40.8
Research and development 363.0 42.3 451.7 23.3 343.8 33.7
Selling, general and administrative 251.7 29.4 418.4 21.6 357.1 35.0
Write-off of purchased in-process technologies - - - - 365.3 35.8
Special change (corporate transactions) 25.0 2.9 - - 49.4 4.8
Restructuring charge - - - - 39.1 3.8
Other - - - - 12.6 1.2
Operating expense 737.6 86.0 1,143.0 5.89 1,583.0 155.1
Operating income before tax and other items 119.7 14.0 796.9 41.1 (562.7) (55.1)
Operating income (loss) before other items 114.3 13.3 560.0 28.9 (587.7) (57.6)
Share of income (loss) of subsidiary - - (53.3) (2.7) 80.4 7.9
Foreign currency translation adjustment - - - - 2.4 .2
Operating income after tax 114.3 13.3 506.7 26.1 (504.9) (49.5)
9-53
Common Size Balance Sheet for Genentech,
Amgen & Chiron
9-54
Trend Analysis:
VF Corporation’s Income Statement
Base in
1998 1997 1996 1995 1994 1993
Sales 126.8 120.9 118.9 117.2 115.1 4,320
Cost of sales 120.6 115.7 116.3 120.2 113.9 2,974
Gross margins 140.6 132.3 124.7 110.3 117.7 1,346
Advertising expense 143.5 154.5 135.5 115.5 109.5 200
Admin and general expense 127.6 121.3 119.2 126.1 115.8 714
Operating income before tax 166.4 135.7 129.8 87.4 129.8 420
Taxes on operating income 157.7 145.2 135.7 90.5 123.8 168
Operating income after tax 172.2 129.0 125.8 85.3 134.1 252
Net financial expense 155.7 82.2 136.4 174.2 189.4 26
Comprehensive income 174.9 134.1 124.3 74.8 127.4 226
Trend analysis of selected financial statement items for VF Corporation, 1994-98. Base = 100 for 1993
9-55
Trend Analysis: VF
Corporation’s Balance Sheet
Base in
1998 1997 1996 1995 1994 1993
Accounts receivable 137.9 114.8 115.8 123.0 119.7 512
Inventory 122.5 99.5 93.8 108.1 102.8 779
Property, plant and equipment (gross) 136.9 125.5 123.4 119.2 112.3
1,250
Property, plant and equipment (net)108.8 99.0 101.3 105.2 107.6 713
Goodwill (gross) 167.1 143.1 152.3 153.3 151.7 715
Goodwill (net) 165.6 141.6 150.3 154.4 158.4 575
Deferred tax asset, before allowance253.7 229.0 182.8 181.7 119.4 93
Deferred tax asset, after allowance 220.9 197.8 153.8 161.5 109.9 91
Operating assets 136.3 115.9 115.2 122.0 119.1 2,794
Accounts payable 138.1 121.9 130.0 112.1 117.8 247
Accrued liabilities 166.4 164.2 159.3 134.0 110.8 268
Other liabilities 143.3 113.4 129.1 133.1 120.5 127
Operating liabilities 151.2 138.1 142.1 125.6 115.6 641
Net operating assets 131.9 109.2 107.2 120.9 120.1 2,153
Financial assets 36.4 84.8 197.7 57.6 38.6 132
Financial obligations 115.5 81.0 80.9 123.2 122.5 737
Net financial obligations 127.9 80.2 55.4 137.5 140.8 605
Common shareholders’ equity 133.5 120.7 127.6 114.5 112.1 1,547
Trend analysis of selected financial statement items for VF Corporation, 1994-98. Base = 100 for 1993
9-56